Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
83
NCT02254369
Safety, Tolerability, and Pharmacokinetic Study of Single Ascending Doses of GC021109 in Healthy Subjects
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2014
Completion: Dec 31, 2014
NCT02386306
Study Evaluating Safety, Tolerability, and PK of Multiple Ascending Doses of GC021109 in Subjects With Mild to Moderate Alzheimer's Disease
Start: Feb 28, 2015
Completion: Oct 31, 2015